• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

BDA Bod signs distribution deal with Uber SecretsPRICE SENSITIVE22/09/17
BDA Annual Report to Shareholders21/09/17
BDA Corporate Governance Statement & Appendix 4G21/09/17
BDA Appendix 4E & Preliminary Final ReportPRICE SENSITIVE31/08/17
BDA Phase I Medicinal Cannabis Clinical Trial Design CompletedPRICE SENSITIVE21/08/17
BDA Initial Director's Interest Notice - Mickey Perret10/08/17
BDA Appointment of Director & Medicinal Cannabis Advisory Board07/08/17
BDA Quarterly Report & Appendix 4CPRICE SENSITIVE31/07/17
BDA Appendix 3B - Release of Shares from Escrow07/07/17
BDA Appendix 3B - Release of Shares from Escrow30/06/17
BDA Distribution agreement with API, a major pharmacy wholesalerPRICE SENSITIVE30/06/17
BDA Bod secures distribution agreement with Ritchie's IGA28/06/17
BDA Restricted Securities to be released from Escrow15/06/17
BDA Bod enters distribution deal with Alpha Inflight ServicesPRICE SENSITIVE23/05/17
BDA Change of Registered Office Address19/05/17
BDA Update on medicinal cannabis - Bod to fast track importationPRICE SENSITIVE17/05/17
BDA Quarterly Report & Appendix 4CPRICE SENSITIVE28/04/17
BDA Market Update05/04/17
BDA Binding LOI to develop products utilising cannabis extractsPRICE SENSITIVE03/04/17
BDA Trading HaltPRICE SENSITIVE30/03/17
BDA Appendix 3B - Issue of Unlisted Options16/03/17
BDA Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
BDA Bod Australia to distribute UK brand Pommade DivinePRICE SENSITIVE08/02/17
BDA Quarterly Report & Appendix 4CPRICE SENSITIVE31/01/17
BDA Investor Presentation31/01/17
BDA Bod Australia Bolsters Distribution ChannelsPRICE SENSITIVE24/01/17
BDA Appendix 3B - Issue of Unlisted Options22/12/16
BDA Agreement with Leading Belgian Natural Medicine ManufacturerPRICE SENSITIVE12/12/16
BDA Change in substantial holding - Joanne Patterson22/11/16
BDA Change of Registered Office & Principle Place of Business17/11/16
BDA Change of Director's Interest Notice - Jo Patterson15/11/16
BDA Initial Director's Interest Notice08/11/16
BDA Initial Director's Interest Notice - Joanne Patterson07/11/16
BDA Initial Director's Interest Notice - Simon Taylor04/11/16
BDA Becoming a substantial holder x204/11/16
BDA BOD Australia to enter natural medicine market with Pinpoint-BDA.AX PRICE SENSITIVE03/11/16
BDA BOD Australia to enter natural medicine market with PinpointPRICE SENSITIVE03/11/16
BDA Bod Australia commences trading on ASX-BDA.AX 27/10/16
BDA Investor Presentation-BDA.AX 27/10/16
BDA Bod signs distribution deal with Uber Secrets
22/09/17PRICE SENSITIVE
BDA Annual Report to Shareholders
21/09/17
BDA Corporate Governance Statement & Appendix 4G
21/09/17
BDA Appendix 4E & Preliminary Final Report
31/08/17PRICE SENSITIVE
BDA Phase I Medicinal Cannabis Clinical Trial Design Completed
21/08/17PRICE SENSITIVE
BDA Initial Director's Interest Notice - Mickey Perret
10/08/17
BDA Appointment of Director & Medicinal Cannabis Advisory Board
07/08/17
BDA Quarterly Report & Appendix 4C
31/07/17PRICE SENSITIVE
BDA Appendix 3B - Release of Shares from Escrow
07/07/17
BDA Appendix 3B - Release of Shares from Escrow
30/06/17
BDA Distribution agreement with API, a major pharmacy wholesaler
30/06/17PRICE SENSITIVE
BDA Bod secures distribution agreement with Ritchie's IGA
28/06/17
BDA Restricted Securities to be released from Escrow
15/06/17
BDA Bod enters distribution deal with Alpha Inflight Services
23/05/17PRICE SENSITIVE
BDA Change of Registered Office Address
19/05/17
BDA Update on medicinal cannabis - Bod to fast track importation
17/05/17PRICE SENSITIVE
BDA Quarterly Report & Appendix 4C
28/04/17PRICE SENSITIVE
BDA Market Update
05/04/17
BDA Binding LOI to develop products utilising cannabis extracts
03/04/17PRICE SENSITIVE
BDA Trading Halt
30/03/17PRICE SENSITIVE
BDA Appendix 3B - Issue of Unlisted Options
16/03/17
BDA Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
BDA Bod Australia to distribute UK brand Pommade Divine
08/02/17PRICE SENSITIVE
BDA Quarterly Report & Appendix 4C
31/01/17PRICE SENSITIVE
BDA Investor Presentation
31/01/17
BDA Bod Australia Bolsters Distribution Channels
24/01/17PRICE SENSITIVE
BDA Appendix 3B - Issue of Unlisted Options
22/12/16
BDA Agreement with Leading Belgian Natural Medicine Manufacturer
12/12/16PRICE SENSITIVE
BDA Change in substantial holding - Joanne Patterson
22/11/16
BDA Change of Registered Office & Principle Place of Business
17/11/16
BDA Change of Director's Interest Notice - Jo Patterson
15/11/16
BDA Initial Director's Interest Notice
08/11/16
BDA Initial Director's Interest Notice - Joanne Patterson
07/11/16
BDA Initial Director's Interest Notice - Simon Taylor
04/11/16
BDA Becoming a substantial holder x2
04/11/16
BDA BOD Australia to enter natural medicine market with Pinpoint-BDA.AX
03/11/16PRICE SENSITIVE
BDA BOD Australia to enter natural medicine market with Pinpoint
03/11/16PRICE SENSITIVE
BDA Bod Australia commences trading on ASX-BDA.AX
27/10/16
BDA Investor Presentation-BDA.AX
27/10/16
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.